Rotavirus vaccination for infants has been recommended in France for all babies since April 2023. According to the Santé publique France bulletin published on April 27, 2026, 54.9% of children in the 2025 cohort had received at least one dose by 8 months of age. The complete schedule reached 44.2%. Progress is clear, but coverage remains lower than that of the other vaccines in the immunization schedule.
This article brings together the official figures currently available: disease burden, vaccination schedules, observed effectiveness, and the known safety signal.
What rotavirus means for infants
Rotavirus is the leading cause of severe acute gastroenteritis in young children. Almost all children are infected at least once before the age of five. The risk lies in rapid dehydration, particularly in children under one year old.
Before vaccination was introduced nationwide, estimates cited by health authorities indicated around 57,000 general-practice consultations each winter. There were also 28,000 emergency department visits and 20,000 hospitalizations among children under three.
In terms of mortality, rotavirus caused approximately three in-hospital deaths per year in France between 2014 and 2019, mainly among infants under one year old.
A seasonal disease
Outbreaks occur mainly between December and April, peaking in February and March. This seasonality partly overlaps with that of bronchiolitis, whose prevention campaign is described in our article on bronchiolitis in infants.
What vaccination schedule is recommended?
Vaccination is recommended for all infants aged 6 weeks to 6 months. It is administered orally, not by injection. Two vaccines are available, with different schedules.
- Rotarix, a monovalent vaccine: two doses, administered at 2 and 3 months of age.
- RotaTeq, a pentavalent vaccine: three doses, administered at 2, 3, and 4 months of age.
The age limits differ depending on the vaccine. The Rotarix schedule must be completed before 6 months, and the RotaTeq schedule before 8 months. Once these limits have passed, vaccination is no longer offered.
This early timing is explained by the epidemiology: severe cases occur mainly between 6 and 24 months, so protection must be in place beforehand. The complete immunization schedule is presented in our article on baby vaccination in France.
What is the vaccination coverage in France?
This is the area in which recent data provide the most information. Santé publique France published a national bulletin on childhood and adolescent vaccination on April 27, 2026.
For the 2025 cohort, measured at 8 months of age, coverage was 54.9% for at least one dose and 44.2% for a complete schedule.
Compared with the 2023 cohort, the first cohort covered by the recommendation, coverage increased by 24.0 percentage points for at least one dose and by 20.4 percentage points for a complete schedule. The trend is therefore real and rapid.
Significant regional disparities
Coverage remains considerably lower in the overseas regions. The bulletin specifically cites French Guiana at 31.3% and Guadeloupe at 27.6%. These differences are particularly significant because access to healthcare is often more limited there.
Is the rotavirus vaccine effective?
Yes, particularly on the outcome that matters most: hospitalizations. The Haute Autorité de santé states that vaccination reduces hospitalizations for acute rotavirus gastroenteritis by 65% to 84%. This result has been observed in countries where vaccination coverage among infants exceeds 80%.
Two points should be noted. First, this level of effectiveness assumes high coverage, which France has not yet reached. Second, the vaccine protects against severe disease, not against every case of gastroenteritis. A vaccinated child may still develop diarrhea, which should generally be milder.
What is the risk of acute intussusception?
This is the known safety signal, and it is documented. The HAS estimates up to 6 cases per 100,000 vaccinated children within 7 days of administration.
Acute intussusception occurs when one section of the intestine folds into another. Symptoms include intense, episodic crying, refusal to feed, vomiting, or blood in the stool. If these signs occur, immediate medical attention is required.
The HAS emphasizes that when detected early by ultrasound, this complication can be treated easily and without serious consequences. This is precisely why informing parents about warning signs is an integral part of the recommendation.
How can transmission be limited at home and in group settings?
Rotavirus is transmitted by the fecal-oral route and survives well on surfaces. Vaccination therefore does not replace hygiene measures, especially during outbreak periods.
- Washing hands with soap and water remains the most effective measure, particularly after every diaper change.
- Alcohol-based hand sanitizers are less effective against this virus than against other infectious agents.
- Surfaces and objects placed in the mouth should be cleaned regularly. Washable mats and toys make this routine much easier, as we explain in our guide to foam mats for babies and in our guide to caring for baby products.
In group settings, transmission is more intense. Guidance on childcare centers and daycare practices is covered in our article on settling into daycare.
The sign that should raise concern
Dehydration is the real danger. Signs to watch for include fewer wet diapers, a dry mouth, unusual sleepiness, and an absence of tears when crying. In an infant, these signs warrant prompt medical advice.
What these figures do—and do not—tell us
Coverage data show rapid adoption across three cohorts, but levels are still far from the threshold at which the collective effects observed abroad become fully measurable. This is evidence of progress, not a final assessment.
They do not, however, tell us how hospitalizations in France have changed since 2023. Impact data require several epidemic seasons and dedicated analysis. The infant gut microbiome, whose role is still being studied, is one of the related topics we cover in our article on the infant microbiome.
Finally, the decision to vaccinate should be made in consultation with the doctor or midwife caring for the child. This article brings together public data; it does not replace professional medical advice.
Sources
- Haute Autorité de santé, “The HAS recommends rotavirus vaccination for infants,” July 12, 2022.
- Santé publique France, national bulletin “Vaccination of children, adolescents, and young adults,” published April 27, 2026.
- Vaccination Info Service, healthcare professionals, “Rotavirus gastroenteritis” fact sheet, accessed September 3, 2026.
